• OPEN AN ACCOUNT
Indian Indices
Sensex
82,031.81 -500.38
( -0.61%)
Global Indices
Nasdaq
50,205.66 -574.76
(-1.13%)
Dow Jones
7,342.05 -19.48
(-0.26%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.96 -0.30
(-0.32%)
EUR-INR
103.45 -0.43
(-0.42%)
GBP-INR
123.99 -0.51
(-0.41%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
432.1356994
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
40.17
114720.11
EPS(TTM)
Face Value()
Div & Yield %
35.35
2
0.92
 

EFC (I) consolidated net profit rises 58.16% in the March 2026 quarter
May 29,2026
Net profit of EFC (I) rose 58.16% to Rs 69.40 crore in the quarter ended March 2026 as against Rs 43.88 crore during the previous quarter ended March 2025. Sales rose 38.80% to Rs 292.88 crore in the quarter ended March 2026 as against Rs 211.01 crore during the previous quarter ended March 2025.

For the full year,net profit rose 62.94% to Rs 231.55 crore in the year ended March 2026 as against Rs 142.11 crore during the previous year ended March 2025. Sales rose 57.85% to Rs 1036.68 crore in the year ended March 2026 as against Rs 656.74 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales292.88211.01 39 1036.68656.74 58
OPM %49.0251.80 -45.1749.89 -
PBDT120.22100.17 20 429.17299.52 43
PBT84.9770.54 20 308.92199.84 55
NP69.4043.88 58 231.55142.11 63